Representatives for the musician clarified the nature of his hospitalization after rumors spread online that he was receiving ...

Try this on drums, and you'll end up with something similar to a classic gated drum kit. Eat your heart out, Phil Collins! If we swing back to our concept of experimentation, a very simple point for ...

The Who has played 'Won't Get Fooled Again' with five drummers, and we're taking a look at their drum solo and Roger Daltrey's primal screams.

Sam Taylor led Oriental Trading before his death in December 2017. Friend Phil Terry says Taylor listened to both customers and colleagues. Editor’s note: In a new book, “The Warren Buffett ...

Which NFL draft picks at edge rusher have provided the best value since the turn of the century 25 years ago? Eric Edholm reveals his top-five ranking, a list that includes a pair of mid-round ...

MICHAEL VAN GERWEN has brutally labelled a darts rival as a “pub player”… but insists he is not being harsh. The savage dig came after the three-time darts world champion defeated… ...

Novo Nordisk's obesity candidate CagriSema has underwhelmed in a second phase 3 trial, sending the company's share into a sharp decline ...

Hank Allen-Barfield is a young, up and coming jazz drummer in New York City. Born and raised in Sacramento, California, Hank picked up the drums at age 10 after being influenced by his father, John ...

BeiGene has decided to stop the development of its TIGIT-targeting drug ociperlimab in yet another setback for the drug class. The Nasdaq-listed company – which is planning to rebrand as BeOne ...

Shares in Summit Therapeutics have risen sharply on a report that AstraZeneca is in discussions for a partnership focused on PD-1xVEGF bispecific ivonescimab that is estimated to be worth as much ...

Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a failed clinical trial.

The WHO has recommended Gilead's twice-yearly HIV PrEP drug lenacapavir, calling it 'transformational', but there are concerns about patient access.